10.0.1.19

Deal Roundup: Permira said to eye $4bn valuation through Cambrex sale, PAI agrees Marcolin exit to VSP Vision

By
Mike Didymus
-
0
Permira is reportedly eyeing a valuation of up to $4bn for contract drugmaker Cambrex, the FT reported. Permira bought t

RELATED ARTICLESMORE FROM AUTHOR